Abstract

Introduction: Men who have sex with men (MSM) are a vulnerable subgroup for problems with substance use, including crystal methamphetamine. Drug use in sexual settings, commonly referred to as “chemsex,” has been an issue of growing concern in MSM communities. Recreational drugs commonly associated with chemsex include crystal methamphetamine, gamma-hydroxybutyrate/gamma-butyrolactone (GHB/GBL), mephedrone, and ketamine. Drug use in sexual settings is correlated with sexual practices associated with the acquisition and transmission of sexually transmitted infections, including HIV and hepatitis C. Adverse mental health outcomes are often reported at higher rates among MSM who use methamphetamine.Methods: This paper refers to a subset of participants from the German Chemsex Survey, an MSM-community recruited, self-completed online survey with a self-selected convenience sample. Participants who used crystal methamphetamine for sex (n = 130) were compared to participants who did not use drugs for sex (n = 177). The survey comprised 420 different items considering recreational substance use, substance use in sexual settings, harm reduction strategies, mental health, sexual transmitted infections, and mental health care service utilization.Results: A total of 1,583 men started the survey; 1,050 participants provided information on substance use. Twenty-seven percent of participants used crystal methamphetamine in the last 12 months, and of those, 89% used methamphetamine in a sexual setting and 50% reported injecting methamphetamine. Regarding mental health, participants who reported methamphetamine use in sexual settings were more likely to report symptoms of depression, somatization, anxiety, and posttraumatic stress disorder (PTSD) than the German male general population. Participants who reported methamphetamine use for sex were more likely to report symptoms of major depression, being HIV positive, and taking HIV pre-exposure prophylaxis (PrEP) than participants who did not report methamphetamine use. Most participants used harm reduction practices to reduce the risks associated with using methamphetamine in sexual settings.Conclusion: Crystal methamphetamine is used in the context of sexual activities by German MSM. Poorer mental health status than in the male general population was observed. MSM who used methamphetamine in this study seemed to be aware of potential health risks associated with their substance use and utilized harm reduction strategies and biomedical HIV prevention strategies like PrEP.

Highlights

  • Men who have sex with men (MSM) are a vulnerable subgroup for problems with substance use, including crystal methamphetamine

  • It has been consistently shown that MSM who use drugs for sex are more likely to be HIV positive [14, 15] and have higher rates of sexually transmitted infections (STIs) and hepatitis C (HCV) [16, 17] than those who do not engage in these practices

  • The present study is focused on two groups: men who reported crystal methamphetamine use in sexual settings in the previous 12 months, and men who reported no illicit drug use in sexual settings in the previous 12 months

Read more

Summary

Introduction

Men who have sex with men (MSM) are a vulnerable subgroup for problems with substance use, including crystal methamphetamine. Drug use in sexual settings, commonly referred to as “chemsex,” has been an issue of growing concern in MSM communities. Drug use in sexual settings, commonly referred to as "chemsex," has been an issue of growing concern in MSM communities in recent years [5]. Recreational drugs commonly associated with chemsex include crystal methamphetamine, gammahydroxybutyrate/gamma-butyrolactone (GHB/GBL), mephedrone, and ketamine, and are typically used with the intention to enhance, intensify, and prolong sexual experiences [2]. It has been consistently shown that MSM who use drugs for sex are more likely to be HIV positive [14, 15] and have higher rates of STIs and hepatitis C (HCV) [16, 17] than those who do not engage in these practices. Current methamphetamine use negatively affects adherence to the antiretroviral therapy (ART) in HIV-positive MSM [19]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call